Carolina Contreras Cuevas/LinkedIn
Oct 24, 2025, 10:03
Debunking Myths with Carolina Contreras Cuevas: The AQUARIUS Trial That Had to Be Stopped
Carolina Contreras Cuevas, Hematologist, Medical Center and Interconsultant Physician at RedSalud CCHC, shared a post on LinkedIn:
“Debunking Myths.
The AQUARIUS study on the use of ASA + anticoagulant (VKA or DOAC) in patients with chronic coronary syndrome, already with a stent implanted for >6 months, and on anticoagulation for another reason.
Spoiler: The study had to be stopped early at 2.2 years.”
Read full paper here.
Stay informed with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda